Effects of trans-10,cis-12 CLA on liver size and fatty acid oxidation under energy restriction conditions in hamsters

Nutrition. 2011 Jan;27(1):116-121. doi: 10.1016/j.nut.2010.01.003. Epub 2010 Aug 8.

Abstract

Objective: Little evidence exists concerning the effects of trans-10,cis-12 conjugated linoleic acid (CLA) under energy restriction. Thus, the effects of this CLA isomer on adipose tissue size, liver composition, as well as on expression and activity of carnitine-palmitoyl transferase I (CPT-I) and acyl CoA oxidase (ACO), in hamsters fed an energy-restricted diet were analyzed.

Methods: Hamsters were fed a high-fat diet for 7 wk and then subjected to 25% energy-restricted diets supplemented with 0.5% linoleic acid or 0.5% trans-10,cis-12 CLA for 3 wk. Serum insulin, free-triiodothyronine and non-esterified fatty acid levels, liver triacylglycerol, protein and water contents, and CPT-I, ACO, and Peroxisome proliferator-activated receptor alpha (PPARα) expressions and enzyme activities were assessed.

Results: Energy restriction reduced liver size, serum levels of insulin, free-triiodothyronine, and non-esterified fatty acid and increased CPT-I activity. Liver composition was not modified. No differences were found between both restricted groups, with the exception of CPT-I and ACO oxidative enzyme activities, which were greater in hamsters fed the CLA diet.

Conclusions: Energy restriction does not cause trans-10,cis-12 CLA to induce liver hyperplasia. Although this CLA isomer increases liver CPT-I and ACO activities, this effect does not result in reduced hepatic triacylglyerol content or decreased adipose tissue size. Consequently, this CLA isomer seems not to be a useful tool for inclusion in body weight loss strategies followed during obesity treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl-CoA Oxidase / metabolism*
  • Animals
  • Caloric Restriction*
  • Carnitine O-Palmitoyltransferase / metabolism*
  • Cricetinae
  • Dietary Fats / adverse effects
  • Dietary Supplements
  • Fatty Acids, Nonesterified / blood
  • Hyperplasia
  • Insulin / blood
  • Isomerism
  • Linoleic Acid / pharmacology
  • Linoleic Acids, Conjugated / pharmacology*
  • Lipid Peroxidation / drug effects*
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mesocricetus
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Obesity / pathology
  • Triiodothyronine / blood

Substances

  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Insulin
  • Linoleic Acids, Conjugated
  • Triiodothyronine
  • Linoleic Acid
  • Acyl-CoA Oxidase
  • Carnitine O-Palmitoyltransferase